Ibrutinib Regimens in Older Patients with Untreated CLL

被引：2
作者：
Diker, Omer [1 ]
机构：
[1] Near East Univ Hosp, Nicosia, Cyprus
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 380卷 / 17期
关键词：
D O I：
10.1056/NEJMc1901284
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1679 / 1679
页数：1
相关论文
共 12 条
  • [1] Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib
    Ahn, Inhye E.
    Jerussi, Theresa
    Farooqui, Mohammed
    Tian, Xin
    Wiestner, Adrian
    Gea-Banacloche, Juan
    [J]. BLOOD, 2016, 128 (15) : 1940 - 1943
  • [2] [Anonymous], 2018, BLOOD, V132, pe1
  • [3] Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
    Barr, Paul M.
    Robak, Tadeusz
    Owen, Carolyn
    Tedeschi, Alessandra
    Bairey, Osnat
    Bartlett, Nancy L.
    Burger, Jan A.
    Hillmen, Peter
    Coutre, Steven
    Devereux, Stephen
    Grosicki, Sebastian
    McCarthy, Helen
    Li, Jianyong
    Simpson, David
    Offner, Fritz
    Moreno, Carol
    Zhou, Cathy
    Styles, Lori
    James, Danelle
    Kipps, Thomas J.
    Ghia, Paolo
    [J]. HAEMATOLOGICA, 2018, 103 (09) : 1502 - 1510
  • [4] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
    Burger, J. A.
    Tedeschi, A.
    Barr, P. M.
    Robak, T.
    Owen, C.
    Ghia, P.
    Bairey, O.
    Hillmen, P.
    Bartlett, N. L.
    Li, J.
    Simpson, D.
    Grosicki, S.
    Devereux, S.
    McCarthy, H.
    Coutre, S.
    Quach, H.
    Gaidano, G.
    Maslyak, Z.
    Stevens, D. A.
    Janssens, A.
    Offner, F.
    Mayer, J.
    O'Dwyer, M.
    Hellmann, A.
    Schuh, A.
    Siddiqi, T.
    Polliack, A.
    Tam, C. S.
    Suri, D.
    Cheng, M.
    Clow, F.
    Styles, L.
    James, D. F.
    Kipps, T. J.
    Keating, Michael
    Jen, Jie
    Jindra, Pavel
    Simkovic, Martin
    Braester, Andrei
    Ruchlemer, Rosa
    Foa, Roberto
    Semenzato, Gianpietro
    Hawkins, Timothy
    Atanasio, Carolina Moreno
    Demirkan, Fatih
    Kaynar, Leylagul
    Pylypenko, Halyna
    Fox, Christopher
    Thirman, Michael
    Campbell, Philip
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) : 2425 - 2437
  • [5] Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways
    Chamilos, Georgios
    Lionakis, Michail S.
    Kontoyiannis, Dimitrios P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (01) : 140 - 148
  • [6] First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
    Eichhorst, Barbara
    Fink, Anna-Maria
    Bahlo, Jasmin
    Busch, Raymonde
    Kovacs, Gabor
    Maurer, Christian
    Lange, Elisabeth
    Koeppler, Hubert
    Kiehl, Michael
    Soekler, Martin
    Schlag, Rudolf
    Vehling-Kaiser, Ursula
    Koechling, Georg
    Ploeger, Christoph
    Gregor, Michael
    Plesner, Torben
    Trneny, Marek
    Fischer, Kirsten
    Doehner, Harmut
    Kneba, Michael
    Wendtner, Clemens-Martin
    Klapper, Wolfram
    Kreuzer, Karl-Anton
    Stilgenbauer, Stephan
    Boettcher, Sebastian
    Hallek, Michael
    [J]. LANCET ONCOLOGY, 2016, 17 (07) : 928 - 942
  • [7] Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
    Ghez, David
    Calleja, Anne
    Protin, Caroline
    Baron, Marine
    Ledoux, Marie-Pierre
    Damaj, Gandhi
    Dupont, Mathieu
    Dreyfus, Brigitte
    Ferrant, Emmanuelle
    Herbaux, Charles
    Laribi, Kamel
    Le Calloch, Ronan
    Malphettes, Marion
    Paul, Franciane
    Souchet, Laetitia
    Truchan-Graczyk, Malgorzata
    Delavigne, Karen
    Dartigeas, Caroline
    Ysebaert, Loic
    [J]. BLOOD, 2018, 131 (17) : 1955 - 1959
  • [8] Ibrutinib: searching for a partner drug
    Kater, Arnon P.
    Brown, Jennifer R.
    [J]. LANCET ONCOLOGY, 2019, 20 (01) : 3 - 5
  • [9] Ventricular arrhythmias and sudden death in patients taking ibrutinib
    Lampson, Benjamin L.
    Yu, Lijian
    Glynn, Robert J.
    Barrientos, Jacqueline C.
    Jacobsen, Eric D.
    Banerji, Versha
    Jones, Jeffrey A.
    Walewska, Renata
    Savage, Kerry J.
    Michaud, Gregory F.
    Moslehi, Javid J.
    Brown, Jennifer R.
    [J]. BLOOD, 2017, 129 (18) : 2581 - 2584
  • [10] Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
    Lionakis, Michail S.
    Dunleavy, Kieron
    Roschewski, Mark
    Widemann, Brigitte C.
    Butman, John A.
    Schmitz, Roland
    Yang, Yandan
    Cole, Diane E.
    Melani, Christopher
    Higham, Christine S.
    Desai, Jigar V.
    Ceribelli, Michele
    Chen, Lu
    Thomas, Craig J.
    Little, Richard F.
    Gea-Banacloche, Juan
    Bhaumik, Sucharita
    Stetler-Stevenson, Maryalice
    Pittaluga, Stefania
    Jaffe, Elaine S.
    Heiss, John
    Lucas, Nicole
    Steinberg, Seth M.
    Staudt, Louis M.
    Wilson, Wyndham H.
    [J]. CANCER CELL, 2017, 31 (06) : 833 - +
12